Patent Services · Pharmaceutical
Pharmaceutical Patent Attorney in Orange County, CA
mjIP represents pharmaceutical inventors and companies across Orange County, San Diego, and the Bay Area. Founding attorney Mandana Jafarinejad, Esq. worked in-house as a patent attorney and research scientist at a Fortune 500 pharmaceutical company before founding the firm — experience that informs how she drafts and prosecutes drug-related patents as part of the firm's patent services.
Pharmaceutical Inventions We Patent
- Drug formulations and compositions
- Dosage forms and controlled-release systems
- Delivery mechanisms and devices
- Synthesis routes and process claims
- Metabolites, polymorphs, and salts
- Methods of treatment and new indications
Industry Experience That Shows Up in the Claims
Pharmaceutical patent value often rests on claim scope and lifecycle strategy — formulation and method-of-treatment claims worded to withstand validity challenges. mjIP drafts with that commercial reality in mind, drawing on real exposure to how drug development and competitive landscapes work.
Prosecution and Litigation
mjIP handles prosecution from prior-art search through office-action responses, and represents clients in pharmaceutical patent disputes where claim construction and validity turn on detailed scientific questions. Coordinate drug branding with a pharmaceutical trademark attorney.
Common Questions
Frequently Asked Questions
Often yes. A new formulation, dosage form, or delivery method may be patentable if novel and non-obvious — for example improved stability, bioavailability, or a controlled-release profile. Method-of-treatment claims may also be available.
It claims the use of a compound to treat a condition rather than the compound itself. These claims can extend protection and are a common part of pharmaceutical lifecycle strategy.
Yes. Attorney Jafarinejad worked in-house as a patent attorney and research scientist at a Fortune 500 pharmaceutical company in Orange County and holds a biology degree, giving her direct familiarity with drug development.